| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |